Analysts’ Recent Ratings Changes for Alignment Healthcare (ALHC)

A number of firms have modified their ratings and price targets on shares of Alignment Healthcare (NASDAQ: ALHC) recently:

• 1/22/2026 – Alignment Healthcare had its “overweight” rating reaffirmed by analysts at KeyCorp. They now have a $28.00 price target on the stock.
• 1/21/2026 – Alignment Healthcare had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings.
• 1/17/2026 – Alignment Healthcare was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 1/16/2026 – Alignment Healthcare had its price target raised by analysts at TD Cowen from $18.50 to $25.00. They now have a “buy” rating on the stock.
• 1/16/2026 – Alignment Healthcare had its price target raised by analysts at TD Cowen from $18.50 to $25.00. They now have a “buy” rating on the stock.
• 1/14/2026 – Alignment Healthcare had its price target raised by analysts at UBS Group AG from $18.00 to $21.00. They now have a “neutral” rating on the stock.
• 1/6/2026 – Alignment Healthcare had its price target raised by analysts at Piper Sandler from $20.00 to $30.00. They now have an “overweight” rating on the stock.
• 12/17/2025 – Alignment Healthcare had its price target raised by analysts at JPMorgan Chase & Co. from $20.00 to $23.00. They now have an “overweight” rating on the stock.

Insider Transactions at Alignment Healthcare

In other news, CEO John E. Kao sold 605,648 shares of the business’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $11,349,843.52. Following the completion of the sale, the chief executive officer owned 2,234,294 shares of the company’s stock, valued at approximately $41,870,669.56. The trade was a 21.33% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Robert L. Scavo sold 69,541 shares of the company’s stock in a transaction on Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $1,303,198.34. Following the sale, the insider owned 503,014 shares of the company’s stock, valued at approximately $9,426,482.36. The trade was a 12.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 2,103,532 shares of company stock worth $40,529,538 in the last three months. Insiders own 6.60% of the company’s stock.

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.